Drugs / 4-methylumbelliferyl trimebutine sulfate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06315387 | Dec 2023 → Dec 2024 | cholecystitis | Valenta Pharm JSC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 4-methylumbelliferyl trimebutine sulfate | “4-methylumbelliferyl trimebutine sulfate, 128 mg” NCT06315387 ↗ |
| Route | Oral | “Multiple Oral Administration” NCT06315387 ↗ |